[American Chemical Society](https://www.acs.org)

No longer accepting applications

$100,000/year for 3 years (total $300,000); 1 award per cycle

Supported innovative academic research in organic and medicinal chemistry with emphasis on new compound discovery for human medicines.

Program ran 2009–2023; currently closed to new applicants.

--- ## Description The Teva Pharmaceuticals Marc A. Goshko Memorial Grant was administered by the American Chemical Society (ACS) and funded by Teva Pharmaceuticals to honor Marc A. Goshko, a key figure in establishing the program. From 2009 to 2023, this grant supported academic researchers ("Teva Scholars") conducting innovative research in organic chemistry with direct or potential applications in medicinal or pharmaceutical chemistry. The main objective was to advance the discovery of new organic compounds with potential use as human medicines. The program prioritized scientific merit, creativity, novelty, and the exploration of under-investigated areas in the field. Recipients were required to present their research at an ACS-agreed venue and submit annual scientific and financial progress reports. --- ## Due Dates - The program is not currently accepting new applications. - Last active cycle: 2009–2023 --- ## Funding Amount - $100,000 per year for 3 years (total $300,000 per award) - Only one award was given per cycle - Award period typically ran from September 1 to August 31 --- ## Eligibility - Applicants had to be recently-tenured faculty members at Ph.D.-granting departments in the United States. - Research proposals needed to focus on organic chemistry with a clear connection to medicinal or pharmaceutical chemistry. - Full eligibility details were provided in the [Eligibility, Terms, and Conditions document](https://www.acs.org/content/dam/acsorg/funding/grants/teva-pharmaceuticals-scholars-grants/teva_etc_2018_v2.pdf). --- ## Application Process - Applications are not being accepted at this time. - When open, applicants submitted proposals with a detailed budget (no institutional overhead allowed), research plan, and supporting documents. - Proposals were evaluated on: - Scientific merit, creativity, and novelty - Relevance to unexplored areas of organic/medicinal chemistry - Feasibility, personnel, and facilities - Consideration of potential challenges --- ## Additional Information - A maximum of $10,000/year could be used for the principal investigator’s salary. - Up to $5,000/year could be used for travel, with mandatory budgeting for presenting results in the third year. - No indirect or administrative costs were allowed. - Past recipients and funded projects can be viewed on the [program page](https://www.acs.org/funding/grants/teva-pharmaceuticals-marc-goshko-memorial-grant/past-recipients.html). --- ## External Links - [Program Overview and Details](https://www.acs.org/content/acs/en/funding/grants/teva-pharmaceuticals-marc-goshko-memorial-grant.html) - [Eligibility, Terms, and Conditions (PDF)](https://www.acs.org/content/dam/acsorg/funding/grants/teva-pharmaceuticals-scholars-grants/teva_etc_2018_v2.pdf) - [Past Recipients](https://www.acs.org/funding/grants/teva-pharmaceuticals-marc-goshko-memorial-grant/past-recipients.html) - [ACS Funding & Awards](https://www.acs.org/funding.html) --- ## Contact Information | Name | Title | Email | Phone | |-----------------|----------------|---------------------------------|--------------| | Dr. Nancy Jensen| Program Manager| [n_jensen@acs.org](mailto:n_jensen@acs.org) | 202-872-6186 | | ACS General | Help Desk | [help@services.acs.org](mailto:help@services.acs.org) | +1 800-227-5558 |

Teva Pharmaceuticals Marc A. Goshko Memorial Grant

Sign in to see full grant listing